2020年11月3日
我们很高兴地宣布,我们的原料药团队连续第二年获得2020年全球仿制药和生物仿制药奖的“年度原料药供应商”称号!我们获得该奖项是因为我们在应对新冠病毒病大流行方面采取了迅速行动, to ensure a continuous supply of APIs to formulators and access to medicines worldwide.
全球仿制药和生物仿制药奖奖励这两个行业的“最佳实践”,并鼓励改进经营方式。
Dr. Reddy's awarded API Supplier of the year award 2020.
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.